Dipna Pharmachem Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
Dipna Pharmachem has a total shareholder equity of ₹375.2M and total debt of ₹194.5M, which brings its debt-to-equity ratio to 51.8%. Its total assets and total liabilities are ₹1.3B and ₹953.9M respectively. Dipna Pharmachem's EBIT is ₹34.3M making its interest coverage ratio 1.7. It has cash and short-term investments of ₹148.9M.
Anahtar bilgiler
51.8%
Borç/özkaynak oranı
₹194.45m
Borç
| Faiz karşılama oranı | 1.7x |
| Nakit | ₹148.94m |
| Eşitlik | ₹375.19m |
| Toplam yükümlülükler | ₹953.87m |
| Toplam varlıklar | ₹1.33b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 543594's short term assets (₹1.3B) exceed its short term liabilities (₹828.4M).
Uzun Vadeli Yükümlülükler: 543594's short term assets (₹1.3B) exceed its long term liabilities (₹125.5M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 543594's net debt to equity ratio (12.1%) is considered satisfactory.
Borcun Azaltılması: 543594's debt to equity ratio has reduced from 1230.6% to 51.8% over the past 5 years.
Borç Kapsamı: 543594's operating cash flow is negative, therefore debt is not well covered.
Faiz Kapsamı: 543594's interest payments on its debt are not well covered by EBIT (1.7x coverage).